Figure 1 | British Journal of Cancer

Figure 1

From: K-ras mutation in the endometrium of tamoxifen-treated breast cancer patients, with a comparison of tamoxifen and toremifene

Figure 1

Semiquantitative analysis of mutations in codon 12 of K-ras using the enriched polymerase chain reaction (PCR)-enzyme-linked minisequence assay (ELMA; Sumitomo Metal Industry, Tokyo, Japan). Lanes 1and 2: toremifene-treated endometrium; lanes 3–8: tamoxifen-treated endometrium. The mutation types as determined by PCR-ELMA for lanes 1, 2, 5 and 8 were GGT (wild type), lane 3 was GAT(+−), lane 4 was GAT (1+), lane 6 was GAT (3+) and lane 7 was GTT (1+). BACK: background.

Back to article page